BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7542466)

  • 1. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
    Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
    Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
    Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
    J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.
    Durazzo M; Philipp T; Van Pelt FN; Lüttig B; Borghesio E; Michel G; Schmidt E; Loges S; Rizzetto M; Manns MP
    Gastroenterology; 1995 Feb; 108(2):455-62. PubMed ID: 7835588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
    Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
    J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
    Clifford BD; Donahue D; Smith L; Cable E; Luttig B; Manns M; Bonkovsky HL
    Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
    Todros L; Saracco G; Durazzo M; Abate ML; Touscoz G; Scaglione L; Verme G; Rizzetto M
    Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic hepatitis C virus infection associated with anti-LKM 1].
    Macenlle R; Yáñez J; Suárez F; Bouso M; Vázquez-Iglesias JL
    Gastroenterol Hepatol; 1996 Apr; 19(4):203-5. PubMed ID: 8665358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune mechanisms in chronic hepatitis B and delta virus infections.
    McFarlane BM; Bridger CB; Smith HM; Antonov KA; Naoumov N; Williams R; McFarlane IG
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):615-21. PubMed ID: 8590155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
    Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
    J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue.
    Kyriatsoulis A; Manns M; Gerken G; Lohse AW; Ballhausen W; Reske K; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1987 Oct; 70(1):53-60. PubMed ID: 3690894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of circulating autoantibodies in healthy individuals].
    Teubner A; Tillmann HL; Schuppan D; Gericke G; Manns MP; Stölzel U
    Med Klin (Munich); 2002 Nov; 97(11):645-9. PubMed ID: 12434272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA).
    Codońer-Franch P; Paradis K; Gueguen M; Bernard O; Costesec AA; Alvarez F
    Clin Exp Immunol; 1989 Mar; 75(3):354-8. PubMed ID: 2702779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.
    Peakman M; Lobo-Yeo A; Mieli-Vergani G; Davies ET; Mowat AP; Vergani D
    Clin Exp Immunol; 1987 Sep; 69(3):543-9. PubMed ID: 3665184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease.
    Han S; Tredger M; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1995 Jan; 21(1):58-62. PubMed ID: 7806169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis.
    Stechemesser E; Klein R; Berg PA
    Hepatology; 1993 Jul; 18(1):1-9. PubMed ID: 8325600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.